Senior insider sale
CEO, President, Secretary at BIOXCEL THERAPEUTICS, INC. — senior position signals high conviction
$21.1K
19.42K shares
What this filing means
MEHTA VIMAL plans to sell 19.42K shares of BIOXCEL THERAPEUTICS, INC. valued at approximately $21.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/20/2026ACC: 0001964306-26-000255
DirectorOfficer· CEO, President, Secretary
Since Nov 2018
19.42K
Shares to sell
$21.1K
Approx. market value
19.42K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
5/4/2026
19.42KTotal acquired19.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 19.42K | — |
| Total | 19.42K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
19.42K
Market value
$21.1K
5/20/2026
Total
Units
19.42K
Value
$21.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/20/2026 | 19.42K | $21.1K | NASDAQ | Planned |
| Total | 19.42K | $21.1K | ||